{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:02:37Z","timestamp":1789434157265,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00573098"],"award-info":[{"award-number":["RS-2025-00573098"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-18362970"],"award-info":[{"award-number":["RS-2025-18362970"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00219297"],"award-info":[{"award-number":["RS-2023-00219297"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2026-25510253"],"award-info":[{"award-number":["RS-2026-25510253"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00219297"],"award-info":[{"award-number":["RS-2023-00219297"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-00573098"],"award-info":[{"award-number":["RS-2025-00573098"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-18362970"],"award-info":[{"award-number":["RS-2025-18362970"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","award":["RS-2024-00334337"],"award-info":[{"award-number":["RS-2024-00334337"]}],"id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","award":["RS-2024-00334337"],"award-info":[{"award-number":["RS-2024-00334337"]}],"id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76757-0","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T07:33:55Z","timestamp":1786779235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Macrophage trained immunity requires a mitochondrial glutamine-restriction checkpoint for antitumor protection in mice"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4961-3938","authenticated-orcid":false,"given":"Ya Chun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9933-3758","authenticated-orcid":false,"given":"Yulseung","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6585-9226","authenticated-orcid":false,"given":"Seonghun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Ah","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-3230","authenticated-orcid":false,"given":"Sunghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6660-8738","authenticated-orcid":false,"given":"Kuglae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Sik","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0554-3592","authenticated-orcid":false,"given":"Hee Chan","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3372-7575","authenticated-orcid":false,"given":"Jung Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"key":"76757_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","volume":"37","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld, A. J. & Hellmann, M. D. Acquired resistance to immune checkpoint inhibitors. Cancer Cell 37, 443\u2013455 (2020).","journal-title":"Cancer Cell"},{"key":"76757_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"76757_CR3","doi-asserted-by":"crossref","unstructured":"Rui, R., Zhou, L. & He, S. Cancer immunotherapies: advances and bottlenecks. Front. Immunol. 14, 1212476 (2023).","DOI":"10.3389\/fimmu.2023.1212476"},{"key":"76757_CR4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis, R. et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 50, 1317\u20131334.e1310 (2019).","journal-title":"Immunity"},{"key":"76757_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray, P. J. Macrophage polarization. Annu. Rev. Physiol. 79, 541\u2013566 (2017).","journal-title":"Annu. Rev. Physiol."},{"key":"76757_CR6","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.imbio.2013.06.003","volume":"218","author":"MR Galdiero","year":"2013","unstructured":"Galdiero, M. R. et al. Tumor associated macrophages and neutrophils in cancer. Immunobiology 218, 1402\u20131410 (2013).","journal-title":"Immunobiology"},{"key":"76757_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","volume":"81","author":"NR Anderson","year":"2021","unstructured":"Anderson, N. R., Minutolo, N. G., Gill, S. & Klichinsky, M. Macrophage-based approaches for cancer immunotherapy. Cancer Res. 81, 1201\u20131208 (2021).","journal-title":"Cancer Res."},{"key":"76757_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","volume":"9","author":"MG Netea","year":"2011","unstructured":"Netea, M. G., Quintin, J. & van der Meer, J. W. Trained immunity: a memory for innate host defense. Cell Host Microbe 9, 355\u2013361 (2011).","journal-title":"Cell Host Microbe"},{"key":"76757_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"76757_CR10","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).","journal-title":"Science"},{"key":"76757_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/imr.13326","volume":"323","author":"P Vuscan","year":"2024","unstructured":"Vuscan, P., Kischkel, B., Joosten, L. A. B. & Netea, M. G. Trained immunity: general and emerging concepts. Immunol. Rev. 323, 164\u2013185 (2024).","journal-title":"Immunol. Rev."},{"key":"76757_CR12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1189\/jlb.5RI0217-064RR","volume":"102","author":"MG Netea","year":"2017","unstructured":"Netea, M. G., Joosten, L. A. B. & van der Meer, J. W. M. Hypothesis: stimulation of trained immunity as adjunctive immunotherapy in cancer. J. Leukoc. Biol. 102, 1323\u20131332 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"76757_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41573-019-0025-4","volume":"18","author":"WJM Mulder","year":"2019","unstructured":"Mulder, W. J. M., Ochando, J., Joosten, L. A. B., Fayad, Z. A. & Netea, M. G. Therapeutic targeting of trained immunity. Nat. Rev. Drug Discov. 18, 553\u2013566 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"76757_CR14","doi-asserted-by":"publisher","first-page":"1427443","DOI":"10.3389\/fimmu.2024.1427443","volume":"15","author":"Y Sui","year":"2024","unstructured":"Sui, Y. & Berzofsky, J. A. Trained immunity inducers in cancer immunotherapy. Front. Immunol. 15, 1427443 (2024).","journal-title":"Front. Immunol."},{"key":"76757_CR15","doi-asserted-by":"crossref","unstructured":"Li, S., Zou, Y., McMasters, A., Chen, F. & Yan, J. Trained immunity: a new player in cancer immunotherapy. eLife 14, e104920 (2025).","DOI":"10.7554\/eLife.104920"},{"key":"76757_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41577-025-01132-x","volume":"25","author":"G Hajishengallis","year":"2025","unstructured":"Hajishengallis, G., Netea, M. G. & Chavakis, T. Trained immunity in chronic inflammatory diseases and cancer. Nat. Rev. Immunol. 25, 497\u2013514 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"76757_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41590-022-01388-8","volume":"24","author":"C Ding","year":"2023","unstructured":"Ding, C. et al. Inducing trained immunity in pro-metastatic macrophages to control tumor metastasis. Nat. Immunol. 24, 239\u2013254 (2023).","journal-title":"Nat. Immunol."},{"key":"76757_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.immuni.2023.12.005","volume":"57","author":"S Moorlag","year":"2024","unstructured":"Moorlag, S. et al. Multi-omics analysis of innate and adaptive responses to BCG vaccination reveals epigenetic cell states that predict trained immunity. Immunity 57, 171\u2013187.e114 (2024).","journal-title":"Immunity"},{"key":"76757_CR19","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41590-022-01354-4","volume":"23","author":"M Jeyanathan","year":"2022","unstructured":"Jeyanathan, M. et al. Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis. Nat. Immunol. 23, 1687\u20131702 (2022).","journal-title":"Nat. Immunol."},{"key":"76757_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2020.09.058","volume":"183","author":"L Kalafati","year":"2020","unstructured":"Kalafati, L. et al. Innate immune training of granulopoiesis promotes anti-tumor activity. Cell 183, 771\u2013785 e712 (2020).","journal-title":"Cell"},{"key":"76757_CR21","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1161\/ATVBAHA.120.315452","volume":"41","author":"C Drummer","year":"2021","unstructured":"Drummer, C. et al. Trained immunity and reactivity of macrophages and endothelial cells. Arterioscler. Thromb. Vasc. Biol. 41, 1032\u20131046 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"76757_CR22","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.4049\/jimmunol.1800085","volume":"200","author":"BA Fensterheim","year":"2018","unstructured":"Fensterheim, B. A. et al. The TLR4 agonist monophosphoryl lipid A drives broad resistance to infection via dynamic reprogramming of macrophage metabolism. J. Immunol. 200, 3777\u20133789 (2018).","journal-title":"J. Immunol."},{"key":"76757_CR23","doi-asserted-by":"publisher","first-page":"622614","DOI":"10.3389\/fimmu.2020.622614","volume":"11","author":"AM Owen","year":"2020","unstructured":"Owen, A. M., Fults, J. B., Patil, N. K., Hernandez, A. & Bohannon, J. K. TLR agonists as mediators of trained immunity: mechanistic insight and immunotherapeutic potential to combat infection. Front Immunol. 11, 622614 (2020).","journal-title":"Front Immunol."},{"key":"76757_CR24","doi-asserted-by":"publisher","first-page":"1044662","DOI":"10.3389\/fimmu.2022.1044662","volume":"13","author":"AM Owen","year":"2022","unstructured":"Owen, A. M. et al. MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages. Front. Immunol. 13, 1044662 (2022).","journal-title":"Front. Immunol."},{"key":"76757_CR25","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41385-022-00528-5","volume":"15","author":"S Zahalka","year":"2022","unstructured":"Zahalka, S. et al. Trained immunity of alveolar macrophages requires metabolic rewiring and type 1 interferon signaling. Mucosal Immunol. 15, 896\u2013907 (2022).","journal-title":"Mucosal Immunol."},{"key":"76757_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/00000441-189407000-00006","volume":"108","author":"WB Coley","year":"1894","unstructured":"Coley, W. B. Treatment of inoperable malignant tumors with the toxines of erysipelas and the bacillus prodigiosus.  Am. J. Med. Sci. 108, 50 (1894).","journal-title":"Am. J. Med. Sci."},{"key":"76757_CR27","first-page":"461","volume":"4","author":"M Shear","year":"1943","unstructured":"Shear, M. & Perrault, A. Chemical treatment of tumors. IX. Reactions of mice with primary subcutaneous tumors to injection of a hemorrhage-producing bacterial polysaccharide. J. Natl. Cancer Inst. 4, 461 (1943).","journal-title":"J. Natl. Cancer Inst."},{"key":"76757_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00001813-200307000-00012","volume":"14","author":"EK Won","year":"2003","unstructured":"Won, E. K., Zahner, M. C., Grant, E. A., Gore, P. & Chicoine, M. R. Analysis of the antitumoral mechanisms of lipopolysaccharide against glioblastoma multiforme. Anticancer drugs 14, 457\u2013466 (2003).","journal-title":"Anticancer drugs"},{"key":"76757_CR29","doi-asserted-by":"publisher","first-page":"10519","DOI":"10.1158\/0008-5472.CAN-07-0079","volume":"67","author":"V Andreani","year":"2007","unstructured":"Andreani, V., Gatti, G., Simonella, L., Rivero, V. & Maccioni, M. Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo. Cancer Res. 67, 10519\u201310527 (2007).","journal-title":"Cancer Res."},{"key":"76757_CR30","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng, S. C. et al. mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).","journal-title":"Science"},{"key":"76757_CR31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","volume":"24","author":"RJ Arts","year":"2016","unstructured":"Arts, R. J. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 24, 807\u2013819 (2016).","journal-title":"Cell Metab."},{"key":"76757_CR32","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.cell.2025.03.048","volume":"188","author":"A Ziogas","year":"2025","unstructured":"Ziogas, A. et al. Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory. Cell 188, 2992\u20133012.e2916 (2025).","journal-title":"Cell"},{"key":"76757_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cmet.2018.09.003","volume":"29","author":"J Dom\u00ednguez-Andr\u00e9s","year":"2019","unstructured":"Dom\u00ednguez-Andr\u00e9s, J. et al. The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity. Cell Metab. 29, 211\u2013220.e215 (2019).","journal-title":"Cell Metab."},{"key":"76757_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.exphem.2023.02.001","volume":"121","author":"A Johansson","year":"2023","unstructured":"Johansson, A. et al. Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells. Exp. Hematol. 121, 6\u201311 (2023).","journal-title":"Exp. Hematol."},{"key":"76757_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.gde.2021.04.007","volume":"70","author":"E H\u00f6rmanseder","year":"2021","unstructured":"H\u00f6rmanseder, E. Epigenetic memory in reprogramming. Curr. Opin. Genet. Dev. 70, 24\u201331 (2021).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"76757_CR36","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jaci.2024.09.005","volume":"154","author":"MG Netea","year":"2024","unstructured":"Netea, M. G. & Joosten, L. A. B. Trained innate immunity: concept, nomenclature, and future perspectives. J. Allergy Clin. Immunol. 154, 1079\u20131084 (2024).","journal-title":"J. Allergy Clin. Immunol."},{"key":"76757_CR37","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo, H. C., Yu, Y. C., Sung, Y. & Han, J. M. Glutamine reliance in cell metabolism. Exp. Mol. Med. 52, 1496\u20131516 (2020).","journal-title":"Exp. Mol. Med."},{"key":"76757_CR38","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L. A., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553\u2013565 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"76757_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","volume":"3","author":"AA Cluntun","year":"2017","unstructured":"Cluntun, A. A., Lukey, M. J., Cerione, R. A. & Locasale, J. W. Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer 3, 169\u2013180 (2017).","journal-title":"Trends Cancer"},{"key":"76757_CR40","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer 16, 619\u2013634 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"76757_CR41","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun, L., Zhang, H. & Gao, P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell 13, 877\u2013919 (2022).","journal-title":"Protein Cell"},{"key":"76757_CR42","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin, J., Byun, J. K., Choi, Y. K. & Park, K. G. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp. Mol. Med. 55, 706\u2013715 (2023).","journal-title":"Exp. Mol. Med."},{"key":"76757_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","volume":"31","author":"HC Yoo","year":"2020","unstructured":"Yoo, H. C. et al. A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells. Cell Metab. 31, 267\u2013283.e212 (2020).","journal-title":"Cell Metab."},{"key":"76757_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"I Mitroulis","year":"2018","unstructured":"Mitroulis, I. et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 172, 147\u2013161.e112 (2018).","journal-title":"Cell"},{"key":"76757_CR45","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.cell.2022.03.043","volume":"185","author":"X Li","year":"2022","unstructured":"Li, X. et al. Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell 185, 1709\u20131727.e1718 (2022).","journal-title":"Cell"},{"key":"76757_CR46","doi-asserted-by":"publisher","first-page":"1251086","DOI":"10.1126\/science.1251086","volume":"345","author":"S Saeed","year":"2014","unstructured":"Saeed, S. et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 345, 1251086 (2014).","journal-title":"Science"},{"key":"76757_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2020.10.011","volume":"54","author":"S Fanucchi","year":"2021","unstructured":"Fanucchi, S., Dom\u00ednguez-Andr\u00e9s, J., Joosten, L. A. B., Netea, M. G. & Mhlanga, M. M. The intersection of epigenetics and metabolism in trained immunity. Immunity 54, 32\u201343 (2021).","journal-title":"Immunity"},{"key":"76757_CR48","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085\u20132088 (1998).","journal-title":"Science"},{"key":"76757_CR49","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","volume":"162","author":"K Hoshino","year":"1999","unstructured":"Hoshino, K. et al. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749\u20133752 (1999).","journal-title":"J. Immunol."},{"key":"76757_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64730-2","volume":"16","author":"Y Sung","year":"2025","unstructured":"Sung, Y. et al. Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var. Nat. Commun. 16, 9690 (2025).","journal-title":"Nat. Commun."},{"key":"76757_CR51","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1016\/j.immuni.2024.08.018","volume":"57","author":"A Lercher","year":"2024","unstructured":"Lercher, A. et al. Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease. Immunity 57, 2530\u20132546.e2513 (2024).","journal-title":"Immunity"},{"key":"76757_CR52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-immunol-081619-104850","volume":"38","author":"DG Ryan","year":"2020","unstructured":"Ryan, D. G. & O\u2019Neill, L. A. J. Krebs cycle reborn in macrophage immunometabolism. Annu. Rev. Immunol. 38, 289\u2013313 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"76757_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/bs.acr.2019.03.004","volume":"143","author":"C Guo","year":"2019","unstructured":"Guo, C. et al. Immunometabolism: a new target for improving cancer immunotherapy. Adv. Cancer Res. 143, 195\u2013253 (2019).","journal-title":"Adv. Cancer Res."},{"key":"76757_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","volume":"38","author":"J Van den Bossche","year":"2017","unstructured":"Van den Bossche, J., O\u2019Neill, L. A. & Menon, D. Macrophage immunometabolism: where are we (Going)? Trends Immunol. 38, 395\u2013406 (2017).","journal-title":"Trends Immunol."},{"key":"76757_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/science.abj8894","volume":"379","author":"M Hata","year":"2023","unstructured":"Hata, M. et al. Past history of obesity triggers persistent epigenetic changes in innate immunity and exacerbates neuroinflammation. Science 379, 45\u201362 (2023).","journal-title":"Science"},{"key":"76757_CR56","doi-asserted-by":"publisher","first-page":"13505","DOI":"10.1074\/jbc.R000025200","volume":"276","author":"N Vo","year":"2001","unstructured":"Vo, N. & Goodman, R. H. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276, 13505\u201313508 (2001).","journal-title":"J. Biol. Chem."},{"key":"76757_CR57","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1128\/MCB.01489-07","volume":"28","author":"LN Tsai","year":"2008","unstructured":"Tsai, L. N., Ku, T. K., Salib, N. K. & Crowe, D. L. Extracellular signals regulate rapid coactivator recruitment at AP-1 sites by altered phosphorylation of both CREB binding protein and c-jun. Mol. Cell Biol. 28, 4240\u20134250 (2008).","journal-title":"Mol. Cell Biol."},{"key":"76757_CR58","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","volume":"13","author":"MI Gross","year":"2014","unstructured":"Gross, M. I. et al. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol. Cancer Ther. 13, 890\u2013901 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"76757_CR59","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccell.2014.12.006","volume":"27","author":"L Jin","year":"2015","unstructured":"Jin, L. et al. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell 27, 257\u2013270 (2015).","journal-title":"Cancer Cell"},{"key":"76757_CR60","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis, C. D. & Jenuwein, T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487\u2013500 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"76757_CR61","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides, T. Chromatin modifications and their function. Cell 128, 693\u2013705 (2007).","journal-title":"Cell"},{"key":"76757_CR62","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/s12276-022-00902-0","volume":"54","author":"J Yoo","year":"2022","unstructured":"Yoo, J. et al. Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis. Exp. Mol. Med. 54, 2107\u20132117 (2022).","journal-title":"Exp. Mol. Med."},{"key":"76757_CR63","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s42255-024-01059-y","volume":"6","author":"SA Barritt","year":"2024","unstructured":"Barritt, S. A., DuBois-Coyne, S. E. & Dibble, C. C. Coenzyme A biosynthesis: mechanisms of regulation, function and disease. Nat. Metab. 6, 1008\u20131023 (2024).","journal-title":"Nat. Metab."},{"key":"76757_CR64","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"PS Liu","year":"2017","unstructured":"Liu, P. S. et al. \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat. Immunol. 18, 985\u2013994 (2017).","journal-title":"Nat. Immunol."},{"key":"76757_CR65","doi-asserted-by":"crossref","unstructured":"Cui, J., Yan, X. & Song, J. Glutamine metabolism remodels tumor-associated macrophage: mechanistic explorations and new strategies in translational medicine. Front. Immunol. 16, 1715170 (2026).","DOI":"10.3389\/fimmu.2025.1715170"},{"key":"76757_CR66","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/cac2.12459","volume":"43","author":"X Hu","year":"2023","unstructured":"Hu, X. et al. Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer. Cancer Commun. 43, 909\u2013937 (2023).","journal-title":"Cancer Commun."},{"key":"76757_CR67","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1172\/JCI131859","volume":"130","author":"MH Oh","year":"2020","unstructured":"Oh, M. H. et al. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J. Clin. Invest. 130, 3865\u20133884 (2020).","journal-title":"J. Clin. Invest."},{"key":"76757_CR68","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone, R. D. et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366, 1013\u20131021 (2019).","journal-title":"Science"},{"key":"76757_CR69","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13046-024-02994-0","volume":"43","author":"B Wang","year":"2024","unstructured":"Wang, B., Pei, J., Xu, S., Liu, J. & Yu, J. A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle. J. Exp. Clin. Cancer Res. 43, 74 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"76757_CR70","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1158\/1535-7163.MCT-20-0430","volume":"20","author":"S Varghese","year":"2021","unstructured":"Varghese, S. et al. The glutaminase inhibitor CB-839 (Telaglenastat) Enhances the antimelanoma activity of T-cell-mediated immunotherapies. Mol. Cancer Ther. 20, 500\u2013511 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"76757_CR71","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma, P. et al. Immune checkpoint therapy\u2014current perspectives and future directions. Cell 186, 1652\u20131669 (2023).","journal-title":"Cell"},{"key":"76757_CR72","doi-asserted-by":"publisher","first-page":"1464218","DOI":"10.3389\/fcell.2024.1464218","volume":"12","author":"T Huang","year":"2024","unstructured":"Huang, T., Bei, C., Hu, Z. & Li, Y. CAR-macrophage: breaking new ground in cellular immunotherapy. Front. Cell Dev. Biol. 12, 1464218 (2024).","journal-title":"Front. Cell Dev. Biol."},{"key":"76757_CR73","doi-asserted-by":"publisher","first-page":"100841","DOI":"10.1016\/j.xpro.2021.100841","volume":"2","author":"L Rodriguez de la Fuente","year":"2021","unstructured":"Rodriguez de la Fuente, L., Law, A. M. K., Gallego-Ortega, D. & Valdes-Mora, F. Tumor dissociation of highly viable cell suspensions for single-cell omic analyses in mouse models of breast cancer. STAR Protoc. 2, 100841 (2021).","journal-title":"STAR Protoc."},{"key":"76757_CR74","doi-asserted-by":"crossref","unstructured":"Newton, J. M., Hanoteau, A. & Sikora, A. G. Enrichment and characterization of the tumor immune and non-immune microenvironments in established subcutaneous murine tumors. J. Vis. Exp. 136, e57685 (2018).","DOI":"10.3791\/57685-v"},{"key":"76757_CR75","doi-asserted-by":"publisher","first-page":"101940","DOI":"10.1016\/j.xpro.2022.101940","volume":"4","author":"C Xu","year":"2023","unstructured":"Xu, C. et al. Protocol for detecting macrophage-mediated cancer cell phagocytosis in vitro and in vivo. STAR Protoc. 4, 101940 (2023).","journal-title":"STAR Protoc."},{"key":"76757_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43548-w","volume":"14","author":"S Shang","year":"2023","unstructured":"Shang, S. et al. ID1 expressing macrophages support cancer cell stemness and limit CD8(+) T cell infiltration in colorectal cancer. Nat. Commun. 14, 7661 (2023).","journal-title":"Nat. Commun."},{"key":"76757_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"76757_CR78","doi-asserted-by":"crossref","unstructured":"Van den Bossche, J., Baardman, J. & de Winther, M. P. Metabolic characterization of polarized M1 and M2 bone marrow-derived macrophages using real-time extracellular flux analysis. J. Vis. Exp. 105, e53424 (2015).","DOI":"10.3791\/53424"},{"key":"76757_CR79","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/nprot.2009.151","volume":"4","author":"MR Wieckowski","year":"2009","unstructured":"Wieckowski, M. R., Giorgi, C., Lebiedzinska, M., Duszynski, J. & Pinton, P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat. Protoc. 4, 1582\u20131590 (2009).","journal-title":"Nat. Protoc."},{"key":"76757_CR80","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cmet.2016.07.002","volume":"24","author":"T TeSlaa","year":"2016","unstructured":"TeSlaa, T. et al. \u03b1-Ketoglutarate accelerates the initial differentiation of primed human pluripotent stem cells. Cell Metab. 24, 485\u2013493 (2016).","journal-title":"Cell Metab."},{"key":"76757_CR81","doi-asserted-by":"publisher","first-page":"eabm8161","DOI":"10.1126\/sciimmunol.abm8161","volume":"7","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Succinate dehydrogenase\/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammation. Sci. Immunol. 7, eabm8161 (2022).","journal-title":"Sci. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76757-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76757-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76757-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:03:24Z","timestamp":1789430604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76757-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76757"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76757-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9805"}}